These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18809343)

  • 1. Longitudinal changes in triglycerides according to ANGPTL4[E40K] genotype and longitudinal body weight change in the atherosclerosis risk in communities study.
    Nettleton JA; Volcik KA; Demerath EW; Boerwinkle E; Folsom AR
    Ann Epidemiol; 2008 Nov; 18(11):842-6. PubMed ID: 18809343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate intake modifies associations between ANGPTL4[E40K] genotype and HDL-cholesterol concentrations in White men from the Atherosclerosis Risk in Communities (ARIC) study.
    Nettleton JA; Volcik KA; Hoogeveen RC; Boerwinkle E
    Atherosclerosis; 2009 Mar; 203(1):214-20. PubMed ID: 18599063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial.
    Smart-Halajko MC; Kelley-Hedgepeth A; Montefusco MC; Cooper JA; Kopin A; McCaffrey JM; Balasubramanyam A; Pownall HJ; Nathan DM; Peter I; Talmud PJ; Huggins GS;
    BMC Med Genet; 2011 Jun; 12():89. PubMed ID: 21714923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.
    Dewey FE; Gusarova V; O'Dushlaine C; Gottesman O; Trejos J; Hunt C; Van Hout CV; Habegger L; Buckler D; Lai KM; Leader JB; Murray MF; Ritchie MD; Kirchner HL; Ledbetter DH; Penn J; Lopez A; Borecki IB; Overton JD; Reid JG; Carey DJ; Murphy AJ; Yancopoulos GD; Baras A; Gromada J; Shuldiner AR
    N Engl J Med; 2016 Mar; 374(12):1123-33. PubMed ID: 26933753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a genetic variant in the angiopoietin-like protein 4 gene with metabolic syndrome.
    Kharazmi-Khorassani S; Kharazmi-Khorassani J; Rastegar-Moghadam A; Samadi S; Ghazizadeh H; Tayefi M; Ferns GA; Ghayour-Mobarhan M; Avan A; Esmaily H
    BMC Med Genet; 2019 Jun; 20(1):97. PubMed ID: 31164103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in Type 2 diabetic Tunisian population.
    Abid K; Trimeche T; Mili D; Msolli MA; Trabelsi I; Nouira S; Kenani A
    Lipids Health Dis; 2016 Mar; 15():63. PubMed ID: 27004807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.
    ; Stitziel NO; Stirrups KE; Masca NG; Erdmann J; Ferrario PG; König IR; Weeke PE; Webb TR; Auer PL; Schick UM; Lu Y; Zhang H; Dube MP; Goel A; Farrall M; Peloso GM; Won HH; Do R; van Iperen E; Kanoni S; Kruppa J; Mahajan A; Scott RA; Willenberg C; Braund PS; van Capelleveen JC; Doney AS; Donnelly LA; Asselta R; Merlini PA; Duga S; Marziliano N; Denny JC; Shaffer CM; El-Mokhtari NE; Franke A; Gottesman O; Heilmann S; Hengstenberg C; Hoffman P; Holmen OL; Hveem K; Jansson JH; Jöckel KH; Kessler T; Kriebel J; Laugwitz KL; Marouli E; Martinelli N; McCarthy MI; Van Zuydam NR; Meisinger C; Esko T; Mihailov E; Escher SA; Alver M; Moebus S; Morris AD; Müller-Nurasyid M; Nikpay M; Olivieri O; Lemieux Perreault LP; AlQarawi A; Robertson NR; Akinsanya KO; Reilly DF; Vogt TF; Yin W; Asselbergs FW; Kooperberg C; Jackson RD; Stahl E; Strauch K; Varga TV; Waldenberger M; Zeng L; Kraja AT; Liu C; Ehret GB; Newton-Cheh C; Chasman DI; Chowdhury R; Ferrario M; Ford I; Jukema JW; Kee F; Kuulasmaa K; Nordestgaard BG; Perola M; Saleheen D; Sattar N; Surendran P; Tregouet D; Young R; Howson JM; Butterworth AS; Danesh J; Ardissino D; Bottinger EP; Erbel R; Franks PW; Girelli D; Hall AS; Hovingh GK; Kastrati A; Lieb W; Meitinger T; Kraus WE; Shah SH; McPherson R; Orho-Melander M; Melander O; Metspalu A; Palmer CN; Peters A; Rader D; Reilly MP; Loos RJ; Reiner AP; Roden DM; Tardif JC; Thompson JR; Wareham NJ; Watkins H; Willer CJ; Kathiresan S; Deloukas P; Samani NJ; Schunkert H
    N Engl J Med; 2016 Mar; 374(12):1134-44. PubMed ID: 26934567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in ANGPTL4 and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
    Folsom AR; Peacock JM; Demerath E; Boerwinkle E
    Metabolism; 2008 Nov; 57(11):1591-6. PubMed ID: 18940399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk.
    Talmud PJ; Smart M; Presswood E; Cooper JA; Nicaud V; Drenos F; Palmen J; Marmot MG; Boekholdt SM; Wareham NJ; Khaw KT; Kumari M; Humphries SE; ;
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2319-25. PubMed ID: 18974381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk.
    Smart-Halajko MC; Robciuc MR; Cooper JA; Jauhiainen M; Kumari M; Kivimaki M; Khaw KT; Boekholdt SM; Wareham NJ; Gaunt TR; Day IN; Braund PS; Nelson CP; Hall AS; Samani NJ; Humphries SE; Ehnholm C; Talmud PJ
    Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2277-82. PubMed ID: 20829508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4.
    Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Roell WC; Konrad RJ
    Biochem Biophys Res Commun; 2021 Jan; 534():498-503. PubMed ID: 33239171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of loss-of-function in angiopoietin-like 4 on the human phenome.
    Gagnon E; Bourgault J; Gobeil É; Thériault S; Arsenault BJ
    Atherosclerosis; 2024 Jun; 393():117558. PubMed ID: 38703417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The A-allele of the common FTO gene variant rs9939609 complicates weight maintenance in severe obese patients.
    Woehning A; Schultz JH; Roeder E; Moeltner A; Isermann B; Nawroth PP; Wolfrum C; Rudofsky G
    Int J Obes (Lond); 2013 Jan; 37(1):135-9. PubMed ID: 22310469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patients.
    Muendlein A; Saely CH; Leiherer A; Fraunberger P; Kinz E; Rein P; Vonbank A; Zanolin D; Malin C; Drexel H
    Atherosclerosis; 2014 Dec; 237(2):632-8. PubMed ID: 25463098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANGPTL4 gene E40K variation protects against obesity-associated dyslipidemia in participants with obesity.
    Bailetti D; Bertoccini L; Mancina RM; Barchetta I; Capoccia D; Cossu E; Pujia A; Lenzi A; Leonetti F; Cavallo MG; Romeo S; Baroni MG
    Obes Sci Pract; 2019 Feb; 5(1):83-90. PubMed ID: 30820332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in ANGPTL4 provides insights into protein processing and function.
    Yin W; Romeo S; Chang S; Grishin NV; Hobbs HH; Cohen JC
    J Biol Chem; 2009 May; 284(19):13213-22. PubMed ID: 19270337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.
    Georgiadi A; Wang Y; Stienstra R; Tjeerdema N; Janssen A; Stalenhoef A; van der Vliet JA; de Roos A; Tamsma JT; Smit JW; Tan NS; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1529-37. PubMed ID: 23640487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
    Miida T; Hirayama S
    Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-like protein 4 serum levels and gene polymorphisms are associated with large artery atherosclerotic stroke.
    He XW; Shen YG; Zhu M; Hu XF; Zheng Z; Liu P; Li C; Zhu F; Jin XP
    J Neurol Sci; 2016 Mar; 362():333-8. PubMed ID: 26944173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.
    Romeo S; Pennacchio LA; Fu Y; Boerwinkle E; Tybjaerg-Hansen A; Hobbs HH; Cohen JC
    Nat Genet; 2007 Apr; 39(4):513-6. PubMed ID: 17322881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.